| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 91,739 | 82,404 | 97,342 | 142,113 | | Cost of Revenue | 57,024 | 54,587 | 61,052 | 78,823 | | | Gross Profit | 34,715 | 27,817 | 36,290 | 63,290 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 39,256 | 37,508 | 36,919 | 55,116 | | Non Recurring | 323 | 247 | 501 | 400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,864) | (9,938) | (1,130) | 7,774 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 23 | 24 | 25 | | Earnings Before Interest And Taxes | (9,411) | (10,448) | (1,106) | 7,799 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (9,411) | (10,448) | (1,106) | 7,799 | | Income Tax Expense | (4,648) | (4,480) | (280) | 2,822 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,888) | (5,968) | (826) | 4,977 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,763) | (5,968) | (826) | 4,977 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,763) | ($5,968) | ($826) | $4,977 |
|
0.31% Nasdaq 
0.05%
Income Statement
